Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Europe Ophthalmic Devices Market Outlook to 2017
Date:10/11/2011
NEW YORK, Oct. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Europe Ophthalmic Devices Market Outlook to 2017
Europe Ophthalmic Devices Market Outlook to 2017
Summary
GlobalData's new report, "Europe Ophthalmic Devices Market Outlook to 2017" provides key market data on the Europe Ophthalmic Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Countries covered include France, Germany, Italy, Spain and United Kingdom.
- Market size and company share data for Ophthalmic Devices market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- Annualized market revenues (USD million) dat
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. ProteinSimple to Offer Direct Sales, Service and Support for Biologics Products in Europe
2. The Future of European Pharmaceutical Distribution
3. Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America
4. European Pharmaceutical Market: Strategic Assessments of Leading Suppliers
5. European Chemical Market: Strategic Assessments of Leading Suppliers
6. HeartWare Announces Presentation of Clinical Data at the 25th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Lisbon
7. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
8. Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
9. Elsevier Launches European Journal of Cancer iPad Edition
10. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
11. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
Post Your Comments:
(Date:5/22/2013)... ALISO VIEJO, Calif. , May 22, 2013 Avanir ... company management will present an overview of the company at ... Health Care Conference , Presentation date: Wednesday May 29, ... , Jefferies 2013 Global Healthcare Conference , Presentation ... a.m. E.T. A live ...
(Date:5/22/2013)... 22, 2013 Grifols, a global healthcare company based ... from a study demonstrating that a higher dose of ... levels of the alpha 1 protein in patients ... are considered within the normal range for healthy individuals. ... low levels of the alpha 1 proteinase inhibitor ...
(Date:5/22/2013)... CITY , May 22, 2013 ... today announced it received 510(k) clearance from the ... diagnostic X-ray image processing workstation that combines radio ... one platform. Varian,s Nexus DRF Digital X-Ray Imaging ... variety of image receptors, including CCD cameras and ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2[0] Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences[0] Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency[0] Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
... Oct. 5, 2011 Alma Lasers, a global developer, ... devices for aesthetic and medical applications, announced today that ... program in honor of National Breast Cancer Awareness Month. ... breast cancer survivors during the month of October 2011. ...
... 5, 2011 More than 40 million U.S. ... at home" due to the benefits of a subscription-based ... is a service provider that delivers a suite of ... healthcare to also include meals, transportation, and financial solutions. ...
Cached Medicine Technology:In Honor of National Breast Cancer Awareness Month, Alma Lasers Launches Nationwide Radiation Tattoo Removal Program, Declare Your Freedom 2A New Model of Healthcare is Unveiled, Offering Seniors Control, Independence and Dignity as They Age 2A New Model of Healthcare is Unveiled, Offering Seniors Control, Independence and Dignity as They Age 3(Date:5/22/2013)... (PRWEB) May 22, 2013 The ... Rensselaer Polytechnic Institute today announced an affiliation agreement ... of new diagnostic tools and treatments that promote ... signing ceremony on May 22, 2013. , The ... in engineering and invention prototyping and Mount Sinai’s ...
(Date:5/22/2013)... 22, 2013 Many problems can arise from ... pain for a patient if left untreated. Patients suffer ... be easily fixed through occlusal adjustment. A patient experiencing ... back pain should have their dentist check their bite for ... and can lead to problems if the bite is not ...
(Date:5/22/2013)... the current online edition of " The Lancet ... up new possibilities of early diagnosis and smooth ... the patient,s nervous system is irreparably damaged. , ... of the cerebellum and other parts of the ... their muscles. They also suffer from balance disorders ...
(Date:5/22/2013)... turns off cancer. However, when existing drugs boost p53, only a ... published in the journal Cell Reports shows how: tumors ... of the protein p21 than the protein PUMA; tumors that die ... current study shows a handful of genes that control this ratio. ... cancer genes. Tumors turn it off and then they can avoid ...
(Date:5/22/2013)... developed a new drug delivery system that allows inhalation ... in laboratory and animal tests it appears to reduce ... improving the treatment of lung tumors. , This advance ... existing cancer drugs, and small interfering RNA (siRNA) that ... attack. , The combination of these forces resulted in ...
Breaking Medicine News(10 mins):Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 3Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 4Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 5Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 6Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 7Health News:Dr. Martin N. Gorman: Make Headaches, Sensitive Teeth and Neck or Back Pain a Thing of the Past 2Health News:A pan-European study: Signs of motor disorders can appear years before disease manifestation 2Health News:A pan-European study: Signs of motor disorders can appear years before disease manifestation 3Health News:Study details genes that control whether tumors adapt or die when faced with p53 activating drugs 2Health News:Research offers promising new approach to treatment of lung cancer 2[0] Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration[0] Dr. Martin N. Gorman: Make Headaches, Sensitive Teeth and Neck or Back Pain a Thing of the Past[0] A pan-European study: Signs of motor disorders can appear years before disease manifestation[0] Study details genes that control whether tumors adapt or die when faced with p53 activating drugs[0] Research offers promising new approach to treatment of lung cancer
... response to identify and treat people with inhalation anthrax ... attack , however distinguishing // someone who has anthrax ... another respiratory-related illness is the question that has remained ... out to answer .They compared 47 cases of anthrax ...
... could be the first step in the path for a ... first time they have found a successful way to deliver ... mouse. ,Gene therapy for muscular dystrophy has been ... the whole body has been a major obstacle for scientists. ...
... Patients who have a history of an ischemic stroke, which ... put on the drug clopidogrel. // However, new research shows ... had a stroke. ,Researchers conducted a study to see ... be beneficial as it is in heart disease patients.The study ...
... a viral infection of the vestibular nerve. A person who ... neuritis. A new study shows steroids could be the ... conducted a study to see if a steroid drug, antiviral ... outcome of patients with vestibular neuritis. For the study, 141 ...
... increase a person’s risk of developing dementia later in life, ... a recent study conducted, researchers followed nearly 1,500 participants for ... in middle age were twice as likely to develop dementia ... high blood pressure in middle age were six-times more likely ...
... middle age has taken its toll on active baby boomers. ... //for many of the 78 million middle-aged Americans. Now a ... Baroli is finally back on his feet, crouching and clicking, ... knees. "My knees are like my lifeblood," he says. "If ...
Cached Medicine News:0.5mm 1X2 Teeth with 6mm Tying Platform; in Stainless Steel 125...
... Advantage Chair and Stand is one of ... systems available, yet it does not compromise ... the use of durable mechanical components.,The Advantage ... the eyecare professional who demands the very ...
... the first and always the,best refracting ... standard after nearly 80 years. Every Phoroptor ... smooth rotation of the dials. The virtual ... precise, solid click of the control knobs. ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |